false
Hamburger Menu
Catalog
Overview of NTRK as a Target
Overview of NTRK as a Target
Podcast | English | 2022 | 26 Min
Create Account
Credit
No Credit Offered
Summary
Neurotrophic tyrosine receptor kinase fusion, or NTRK, has emerged in the last six years as a rare, but targetable alteration in several cancers. Dr. Herbert Loong, clinical assistant professor in the department of clinical oncology and deputy medical director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong, joins Lung Cancer Considered host Dr. Stephen Liu to discuss NTRK and what impact it may have on lung cancer research and treatment.
Faculty
Dr. Herbert Loong
Dr. Stephen Liu
×
Overview of NTRK as a Target Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English